← SynDRA
CT-1812
SynDRA canonical compound SYN0044657 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PGRMC1 | TMEM97 |
|---|
| Mechanism of action | sigma receptor antagonist |
|---|
| Indication | alzheimer's disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Zervimesine
- RefChem:1082315
- CT1812
- Sigma-2 receptor antagonist 1
- Zervimesine (USAN)
- ZERVIMESINE [USAN]
- Elayta
- zervimesine [INN]
- UNII-0661V34NTV
- C24H33NO4S
- orb1706634
- SCHEMBL16972400
- SCHEMBL29356484
- GTPL13335
- BDBM349547
- CXC63222
- EX-A2998
- ZB1519
- AKOS040742633
- AT24038
- compiund 7 [PMID: 34531947]
- MS-27690
- HY-111669
- CS-0089606
- US10207991, Ex. Cpd. No. 62
- D13086
- T16883
- zervimesine
- EX-A2998A
- CT-1812 fumarate
- Zervimesine fumarate
- CT1812 fumarate
- UNII-69PP57LR9Q
Look up CT-1812 in the interactive SynDRA portal →